Identification of the chemokine CXCL9 (MIG) as a genetic modifier of liver fibrosis in patients with hepatitis C
Article 2006 en
Authors
HW
HE Wasmuth
TW
T. Wiederholt
ED
Edgar Dahl
Abstract
1 min read
Aims: Liver fibrosis in chronic hepatitis C (HCV) infection is influenced by multiple genetic and exogenous factors. Employing quantitative trait locus (QTL) analysis, we have recently identified the distal haplotype of mouse chromosome 5 as a genetic modifier of liver fibrosis. The present study was designed to validate this genetic association in patients with HCV infection and to investigate the expression of CXCL9 at different stages of fibrosis and in isolated human myofibroblasts of different donors.
Hermann E. Wasmuth, Carmen G. Tag, Eddie Van de Leur, Claus Hellerbrand, Tobias Mueller, Thomas Berg, Gero Puhl, P. Neuhaus, Didier Samuel, Christian Trautwein, Sandip M. Kanse, Ralf Weiskirchen
Hacer Sahin, Erawan Borkham‐Kamphorst, Christoph Kuppe, Mirko Moreno Zaldivar, Christoph Grouls, Muhammad Alsamman, Andreas Nellen, P Schmitz, Daniel Heinrichs, Marie‐Luise Berres, Dennis Doleschel, David Scholten, Ralf Weiskirchen, Marcus J. Moeller, Fabian Kießling, Christian Trautwein, Hermann E. Wasmuth
E. Kovalenko, Frank Tacke, O Gressner, H. Zimmermann, Birgit Lahme, Alfred Janetzko, T. Wiederholt, Thomas Berg, Tobias Müller, Christian Trautwein, Axel M. Gressner, Ralf Weiskirchen
Discussion(0)
No comments yet. Be the first to comment.